Form EFFECT Biotech Acquisition Co
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 9, 2022 4:00 P.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citadel unwinds 80% of Aschenbrenner’s portfolio risk - report
- NWPG Completes Cancellation of 24,800,000 Shares of Common Stock, Reducing Outstanding Share Count
- Myriad Uranium completes acquisition of Rush Rare Metals
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
